Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver Disease
Author:
Preprint
- 1 March 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The frequency of non-alcoholic fatty liver disease (NAFLD) has exacerbated setting diagnostic challenges, which increases the need for reliable non-invasive diagnostic tools. Due to the importance of gut-liver axis in the progression of NAFLD, studies try to reveal microbial signatures in NAFLD, evaluate them as diagnostic biomarkers and to predict the disease progression. The gut microbiome affects human physiology by processing the ingested food to bioactive metabolites. These molecules can penetrate the portal vein and the liver to promote or prevent hepatic fat accumulation. Here findings of human fecal metagenomic and metabolomic studies in relation to NAFLD are reviewed. The studies present mostly distinct and even contradictory findings on microbial metabolites and functional genes in NAFLD. The most reproducing microbial biomarkers are increased lipopolysaccharides and peptidoglycan biosynthesis, enhanced degradation of lysine, increased levels of branched chain amino acids as well as altered lipid and carbohydrate metabolism. Among other causes, the discrepancies between the studies may be related to the obesity status of the patients and severity of NAFLD. In none of the studies except one, diet was considered, though it is an important factor driving the gut microbiota metabolism. The future studies should consider diet in the analyses.Keywords
All Related Versions
This publication has 78 references indexed in Scilit:
- Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLDHepatology, 2022
- Insights from shotgun metagenomics into bacterial species and metabolic pathways associated with NAFLD in obese youthHepatology Communications, 2022
- Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver diseaseHepatology, 2016
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiotaHepatology, 2015
- Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver diseaseHepatology, 2013
- Intestinal microbiota in patients with nonalcoholic fatty liver diseaseHepatology, 2013
- Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver diseaseHepatology, 2011
- Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits HypothesisHepatology, 2010
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of EthnicityHepatology, 2004
- Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathwayHepatology, 2004